Status:
COMPLETED
Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements
Lead Sponsor:
Yale University
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to compare the feasibility and accuracy of two methods of non-invasive hemodynamic assessments - bioreactance as assessed by non-invasive cardiac output monitoring (NICOM;...
Eligibility Criteria
Inclusion
- BP \>160 or DBP \>110
- gestational age between 20-34 weeks
- singleton pregnancy
Exclusion
- prior diagnosis of chronic hypertension or hypertensive disorder of pregnancy
- multi-fetal pregnancy
Key Trial Info
Start Date :
December 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05299229
Start Date
December 29 2020
End Date
December 31 2021
Last Update
August 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University Hospital
New Haven, Connecticut, United States, 06510